The interactions between tubocurarine, pancuronium and alcuronium on neuromuscular transmission have been studied in an isolated neuromusciilar preparation (the rat phrenic nerve-hemidiaphragm). Mixtures of tubocurarine and pancuronium, and tubocurarine and alcuronium were found to have a more potent effect than the additive effects of the individual agents when given alone, that is, mixtures were synergisuc. Mixtures of alcuronium and pancuronium did not exhibit this phenomenon. Possible mechanisms for these findings are discussed.
Mixtures of competitive neuromusciilar blocking drugs are used clinically because greater cardiovascular stability can be obtained with the mixture than with the individual drugs (Hill et al.,, 1981) . However, interactions between certain of the neuromuscular blocking drugs have been reported. Mixtures of pancuronium with tubocurarine and pancuronium with di-methyl tubocurarine are synergisticinman (Lebowitzetal., 1980) , while a mixture of pancuronium with alcuronium does not display this phenomenon (Shanks, 1982) . Mixtures of gallamine with tubocurarine may also exhibit synergy (Wong, 1969; Ghoneim et al., 1972) .
We have studied the neuromuscular blocking effects of tubocurarine, pancuronium, alcuronium, and the three two-component mixtures of these drugs in an isolated neuromuscular preparation (the rat phrenic nerve-hemidiaphragm), so as to investigate further aspects of the phenomenon of synergy and to elucidate the possible mechanism for this effect.
Wistar rats weighing between 280 and 350 g were sacrificed and both hemidiaphragms dissected out, together with their accompanying phrenic nerves. These were transferred to a dish containing oxygenated Krebs solution at room temperature. The preparations were attached to carrier assemblies and placed in identical organ baths of 50 ml capacity containing oxygenated Krebs solution maintained at 37 °C. The hemidiaphragms were stimulated indirectly through the nerve and directly across the muscle using supramaximal square wave stimuli. Direct and indirect stimuli were administered alternately with an overall frequency of 0.5 Hz.
The muscle twitch was recorded using an isometric force transducer and displayed on a Grass multichannel polygraph. The tension on the muscle was maintained at 1.5 g. The agents under investigation were added to the bath in a volume of 0.5 ml, to o ( btain the desired final concentration. A contact time of 5 min was chosen since this was found to give repeatable, reliable, maximal responses. The wash time was 15 min, with a further 20 min wash cycle allowed between different agents. Preliminary experiments in our laboratory had shown that cumulation did riot occur when using this technique. The depression of twitch height was measured and expressed as a percentage with respect to the twitch height before the addition of the agent. The order of administration of the drugs and mixtures was varied in a random manner throughout.
Preliminary log dose-response curves were constructed for pancuronium, tubocurarine and alcuronium (n = 5) and the concentrations required to depress twitch height by 50% (ED*,) defined as one dose unit. One dose unit of pancuronium was 2.7 x 10~6 mol litre" 1 , one dose unit of tubocurarine was 1 x 10~6 mol litre" 1 , and one dose unit of alcuronium was 1.4 x 10~6 mol litre"
1 . Mixtures of pancuronium with tubocurarine, pancuronium with alcuronium, and alcuronium with tubocurarine were prepared. Each combination was mixed in the following proportions:
(1) 0.3 dose units of each (total 0.6 dose units).
(2) 0.4 dose units of each (total 0.8 dose units).
(3) 0.5 dose units of each (total 1.0 doseunits). Using suitable concentrations, log dose-response curves (with a minimum of three points each) were plotted for the individual drugs and for the mixtures in the above proportions. In the case of pancuronium with tubocurarine this was repeated on 20 separate phrenic nerve-hemidiaphragm preparations and in the cases of tubocurarine with alcuronium and pancuronium with alcuronium, on 12 separate phrenic nerve-hemidiaphragm preparations. The EDJO expressed in dose units was recorded. The results for each mixture were then compared with those of each of its components using Student's ttest.
RESULTS
The ED,o for tubocurarine, pancuronium and their mixture are shown in table I. The mean for the mixture was lower than that for either drug alone. This difference was significant at the P <0.001 level between pancuronium and the mixture and also between tubocurarine and the mixture. There was no significant difference between the results for the two individual drugs. The log dose-response curves drawn from the means of the individual results for tubocurarine, pancuronium and their mixture are shown in figure 1. The lines have been constructed by regression analysis. The log dose-response curves for the two individual agents can be seen to be close together, while that for the mixture is displaced towards the left. The log dose-response curve for tubocurarine appears less steep than that for pancuronium, but this difference was not statistically significant.
The data for tubocurarine, alcuronium and their mixture are given in table II. The mean ED*, of the mixture was lower than that for either drug alone, and this difference was significant at the i'<0.001 level between tubocurarine and the mixture, and also between alcuronium and the mixture. There was no significant difference between the results for the two individual drugs. In figure 2 , the log dose-response curves constructed by regression analysis from all of the individual data for tubocurarine, alcuronium and their mixture are shown. The curve for the mixture was displaced towards the left from the position occupied by the two individual agents. The log dose-response curve for tubocurarine appears less steep than that for alcuronium, but this difference was not statistically significant.
The ED50 values for pancuronium, alcuronium and their mixture are shown in table III. There were no significant differences between either of the drugs and the mixture, or between the agents themselves. The log dose -response curves constructed by regression analysis from all of the individual data for pancuronium, alcuronium and their mixture are shown in figure 3 . The three almost parallel lines are positioned close together with no evidence of any displacement. There were no statistically significant differences between the slopes of the curves.
DISCUSSION
The results demonstrate clearly synergy between pancuronium and tubocurarine, and between alcuronium and tubocurarine, but not between pancuronium and alcuronium. Thus, support for previously reported findings (Lebowitz et al., 1980; Shanks, 1982) is evident.
In the intact animal, any of a multiplicity of pharmacokinetic factors may be implicated in the formation of drug interactions, for example variations in protein binding and in distribution. Alterations in muscle blood flow have been shown not to be implicated (GhoneimetaL, 1972) . In this isolated preparation, the majority of these factors are not operable, yet synergy was observed. Thus, it appears that this phenomenon is produced primarily by actions taking place within the neuromuscular junction itself. Neuromuscular blocking drugs act on at least four sites in the neuromuscular junction, namely the preand post-junctional acetylcholine receptor sites and their corresponding ion channels (Bowman, 1980) . The post-junctional receptors are those classically implicated in neuromuscular transmission and their stimulation by pre-junctionally released acetylcholine initiates the excitation-contraction coupling mechanism of the muscle. The pre-junctional cholinoceptors are regarded as being more concerned with transmitter mobilization and release (Bowman, 1980) . In addition, they appear to resemble the nicotinic receptors in autonomic ganglia (Bowman, 1980) . Standaert (1964) , has emphasized that a decrease in pre-junctional stimulus and an increase in postjunctional threshold should reinforce each other. Tubocurarine has been shown to decrease the release of acetylcholine (Hubbard, Wilson and Miyamoto, 1969; Galindo, 1972) and, in addition, has significant autonomic ganglion blocking activity which pancuronium and alcuronium lack (Bowman, 1982) . Therefore pancuronium and alcuronium are predominantly post-synaptic blockers, while tubocurarine does have pre-synaptic effects. Consequently, when a combination of pancuronium and tubocurarine is administered, simultaneous preand post-junctional receptor blockade will lead to a reinforcement of the block (that is the mixtures will display synergy). When administering a mixture of alcuronium and pancuronium, synergy will not occur, since neither agent decreases pre-junctional stimulus. While this proposal may explain satisfactorily the reported interactions between the three drugs under investigation, it is likely that each possesses its own spectrum of activity which includes both pre-and post-junctional effects, the emphasis varying between the different agents.
Additional support for this proposal may be gained from an inspection of the log dose-response curves. While statistical significance was not evident, the apparent differences in slope between the log dose-response curve for tubocurarine and those for alcuronium and pancuronium may indicate differing mechanisms of action. Furthermore, the structural similarity between the alcuronium and pancuronium molecules is greater than between either of these and tubocurarine.
We conclude that specific junctional effects are an important mechanism for the phenomenon of synergy between competitive neuromuscular blocking drugs, and that simultaneous pre-and postĵ unctional blockade is a theory of synergy which is compatible with our own observations, and those of other workers.
INTERACTIONS ENTRE TUBOCURARINE, PANCURONIUM ET ALCURONIUM MISES EN EVIDENCE SUR UNE PREPARATION NERF PHRENIQUE-HEMIDIAPHRAGME CHEZ LE RAT

